New Zealand markets closed

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
12.00+0.50 (+4.35%)
At close: 04:00PM EDT
11.76 -0.24 (-2.00%)
After hours: 07:32PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close11.50
Open11.40
Bid11.97 x 200
Ask12.04 x 100
Day's range11.40 - 12.14
52-week range9.76 - 56.37
Volume1,375,161
Avg. volume1,187,819
Market cap722.184M
Beta (5Y monthly)0.92
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    SAGE's Huntington's Disease Study Meets Primary Endpoint

    The phase II SURVEYOR study evaluating SAGE's dalzanemdor as a potential treatment for patients with cognition dysfunction caused by Huntington's disease meets its primary endpoint.

  • Investing.com

    Baird predicts steady growth for SAGE Therapeutics at $15 target

    Investing.com - Baird Equity Research has initiated coverage of SAGE Therapeutics Inc (NASDAQ:SAGE), assigning it a neutral rating with a price target of $15.

  • Insider Monkey

    15 Most Depressed States in the US

    In this article, we will be taking a look at the 15 most depressed states in the US. If you are not interested in learning about the global and regional trends in the depression treatment market, head straight to the 5 Most Depressed States in the US. Global and Regional Trends in the Depression Treatment […]